cyclophosphamide

Preferred Label : cyclophosphamide;

MeSH definition : Precursor of an alkylating nitrogen mustard antineoplastic and immunosuppressive agent that must be activated in the LIVER to form the active aldophosphamide. It has been used in the treatment of LYMPHOMA and LEUKEMIA. Its side effect, ALOPECIA, has been used for defleecing sheep. Cyclophosphamide may also cause sterility, birth defects, mutations, and cancer.;

CISMeF synonym : 2H-1,3,2-Oxazaphosphorin-2-amine, N,N-bis(2-chloroethyl)tetrahydro-, 2-oxide; 60007-95-6 (Cyclophosphamide, ( -)-Isomer); 6055-19-2 (Cyclophosphamide monohydrate); cyclophosphamide, ( -)-Isomer; anhydrous, cyclophosphamide; cyclophosphamide monohydrate; cyclophosphane; cytophosphane; monohydrate, cyclophosphamide;

CISMeF acronym : B518;

DeCS synonym : B518;

MeSH hyponym : endoxan; procytox; sendoxan; cyclophosphamide anhydrous; neosar; cyclophosphamide, (S)-Isomer; NSC-26271; cyclophosphamide, (R)-Isomer; cytophosphan; B-518; B 518; B518; NSC 26271; NSC26271;

Related MeSH term : cytoxan;

MeSH CAS label : ( ,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide monohydrate;

MeSH Related Number : cyclophosphamide, (S)-Isomer; cyclophosphamide, (R)-Isomer; 50-18-0 (Cyclophosphamide); 60007-96-7 ((S)-isomer); 60030-72-0 ((R)-isomer); cyclophosphamide anhydrous; 6UXW23996M;

Registry Number MeSH : 50-18-0;

Related CAS MeSH : 60030-72-0 (Cyclophosphamide, (R)-Isomer); 60007-96-7 (Cyclophosphamide, (S)-Isomer); 6UXW23996M (Cyclophosphamide anhydrous);

Wikipedia link : https://en.wikipedia.org/wiki/Cyclophosphamide;

Codes EINECS : 200-015-4;

Is substance : O;

medicament (CISMeF) : O;

UNII : 8N3DW7272P;

InChIKey : PWOQRKCAHTVFLB-UHFFFAOYSA-N;

Details

Origin ID

D003520;

UMLS CUI

C0010583;

ATC code(s)
- cyclophosphamide [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Automatic exact mappings (from CISMeF team)
- Cyclophosphamide [ACR pathology]
- Cytoxan [ICHI extension code]
CISMeF manual mappings
- cyclophosphamide [Substance BNPC]
Currated CISMeF NLP mapping
- Cyclophosphamide [ICD-11 Extension code]
- Cyclophosphamide [LOINC component]
- Cyclophosphamide [ICHI extension code]
- Cyclophosphamide [SMS substance]
- Cyclophosphamide [NCIt concept]
- Cyclophosphamide (substance) [SNOMED CT concept]
- cyclophosphamide [SNOMED Notion]
Pharmacological action(s)
- antineoplastic agents, alkylating [MeSH Descriptor]
- antirheumatic agents [MeSH Descriptor]
- immunosuppressive agents [MeSH Descriptor]
- mutagens [MeSH Descriptor]
- myeloablative agonists [MeSH Descriptor]
Record concept(s)
- (+,-)-2-(bis(2-Chloroethyl)amino)tetrahydro-2H-1,3,2-oxazaphosphorine 2-Oxide Monohydrate [MeSH concept]
- B-518 [MeSH concept]
- Cyclophosphamide Monohydrate [MeSH concept]
- Cyclophosphane [MeSH concept]
- Cytophosphane [MeSH concept]
- NSC-26271 [MeSH concept]
- cyclophosphamide [MeSH concept]
- cyclophosphamide anhydrous [MeSH concept]
- cyclophosphamide, (R)-Isomer [MeSH concept]
- cyclophosphamide, (S)-Isomer [MeSH concept]
- cytophosphan [MeSH concept]
- cytoxan [MeSH concept]
- endoxan [MeSH concept]
- neosar [MeSH concept]
- procytox [MeSH concept]
- sendoxan [MeSH concept]
Related MeSH Supplementary Concept(s)
- (COMPADRI)-III protocol [MeSH Supplementary Concept]
- 2-dechloroethylcyclophosphamide [MeSH Supplementary Concept]
- 3-(1-oxy-2,2,6,6-tetramethyl-4-piperidinyl)cyclophosphamide [MeSH Supplementary Concept]
- 3-hydroxycyclophosphamide [MeSH Supplementary Concept]
- 3-methoxy-1,3,5(10)-estratriene-17(R)-spiro-6'-(2'-(bis-(2-chloroethyl)amino)-2'-oxo-1'-oxa-3'-aza-2'-phosphorane) [MeSH Supplementary Concept]
- 3-methyl-9-(2-oxa-2lambda(5)-2H-1,3,2-oxazaphosphorine-2-cyclohexyl)-3,6,9-triazaspiro(5.5)undecane [MeSH Supplementary Concept]
- 4,6-diphenylcyclophosphamide [MeSH Supplementary Concept]
- 4-S-(hexane-6-ol)sulfidocyclophosphamide [MeSH Supplementary Concept]
- 4-S-(propionic acid)sulfidocyclophosphamide [MeSH Supplementary Concept]
- 4-S-ethanolsulfido-cyclophosphamide [MeSH Supplementary Concept]
- 4-glutathionylcyclophosphamide [MeSH Supplementary Concept]
- 4-hydroperoxydechlorocyclophosphamide [MeSH Supplementary Concept]
- 4-hydroperoxydidechlorocloclophosphamide [MeSH Supplementary Concept]
- 4-hydroxycyclophosphamide [MeSH Supplementary Concept]
- 4-hydroxyperoxycyclophosphamide [MeSH Supplementary Concept]
- 4-ketocyclophosphamide [MeSH Supplementary Concept]
- 4-methylcyclophosphamide [MeSH Supplementary Concept]
- 4-peroxycyclophosphamide [MeSH Supplementary Concept]
- 4-phenylcyclophosphamide [MeSH Supplementary Concept]
- 4-ureidooxycyclophosphamide [MeSH Supplementary Concept]
- 5,5-dimethylcyclophosphamide [MeSH Supplementary Concept]
- 5-chlorocyclophosphamide [MeSH Supplementary Concept]
- 5-fluorocyclophosphamide [MeSH Supplementary Concept]
- 7+3 protocol [MeSH Supplementary Concept]
- AAABC protocol [MeSH Supplementary Concept]
- ABC protocol [MeSH Supplementary Concept]
- ABCDV protocol [MeSH Supplementary Concept]
- ABCM protocol [MeSH Supplementary Concept]
- AC protocol [MeSH Supplementary Concept]
- ACE protocol 1 [MeSH Supplementary Concept]
- ACF protocol [MeSH Supplementary Concept]
- ACFM protocol [MeSH Supplementary Concept]
- ACFT protocol [MeSH Supplementary Concept]
- ACM protocol [MeSH Supplementary Concept]
- ACMFVP protocol [MeSH Supplementary Concept]
- ACOB regimen [MeSH Supplementary Concept]
- ACOMLA protocol [MeSH Supplementary Concept]
- ACOP protocol 2 [MeSH Supplementary Concept]
- ACOP-E protocol [MeSH Supplementary Concept]
- ACOPA II protocol [MeSH Supplementary Concept]
- ACP protocol [MeSH Supplementary Concept]
- ACT regimen [MeSH Supplementary Concept]
- ACVB protocol [MeSH Supplementary Concept]
- ADOC protocol [MeSH Supplementary Concept]
- AIEOP acute lymphoblastic leukemia protocol [MeSH Supplementary Concept]
- ALL-1 protocol [MeSH Supplementary Concept]
- ALL-BFM-95 protocol [MeSH Supplementary Concept]
- ANAVACYM protocol [MeSH Supplementary Concept]
- ARA-COP protocol [MeSH Supplementary Concept]
- AVCF protocol [MeSH Supplementary Concept]
- AVCT protocol [MeSH Supplementary Concept]
- AVLF protocol [MeSH Supplementary Concept]
- AcFuCy protocol [MeSH Supplementary Concept]
- B-8801 protocol [MeSH Supplementary Concept]
- BACOD protocol [MeSH Supplementary Concept]
- BACOD-VP16 protocol [MeSH Supplementary Concept]
- BACT protocol [MeSH Supplementary Concept]
- BAEC protocol [MeSH Supplementary Concept]
- BCD protocol [MeSH Supplementary Concept]
- BCHE protocol [MeSH Supplementary Concept]
- BCOMM protocol [MeSH Supplementary Concept]
- BCP protocol [MeSH Supplementary Concept]
- BCPE protocol [MeSH Supplementary Concept]
- BCPP protocol [MeSH Supplementary Concept]
- BCVP protocol [MeSH Supplementary Concept]
- BEACOPP protocol [MeSH Supplementary Concept]
- BECALM protocol [MeSH Supplementary Concept]
- BEMOP-CA protocol [MeSH Supplementary Concept]
- BFM 78 protocol [MeSH Supplementary Concept]
- BFM-86 protocol [MeSH Supplementary Concept]
- BFM-ALL 81 protocol [MeSH Supplementary Concept]
- BMF phase II protocol [MeSH Supplementary Concept]
- BOP-CISCA-POMB-ACE regimen [MeSH Supplementary Concept]
- BOVAPEC protocol [MeSH Supplementary Concept]
- BUCY-2 protocol [MeSH Supplementary Concept]
- BV-CAP protocol [MeSH Supplementary Concept]
- BVCPP protocol [MeSH Supplementary Concept]
- Berlin-Frankfurt-Muenster protocol II [MeSH Supplementary Concept]
- BuCEt protocol [MeSH Supplementary Concept]
- C-VAMP protocol [MeSH Supplementary Concept]
- CAC protocol [MeSH Supplementary Concept]
- CAD protocol 3 [MeSH Supplementary Concept]
- CADOM protocol [MeSH Supplementary Concept]
- CAE-P protocol [MeSH Supplementary Concept]
- CAEVM protocol [MeSH Supplementary Concept]
- CAF protocol [MeSH Supplementary Concept]
- CAF protocol 2 [MeSH Supplementary Concept]
- CAF-PH protocol [MeSH Supplementary Concept]
- CAFVP protocol [MeSH Supplementary Concept]
- CALF protocol [MeSH Supplementary Concept]
- CAM combination [MeSH Supplementary Concept]
- CAMBO-VIP protocol [MeSH Supplementary Concept]
- CAMEO protocol [MeSH Supplementary Concept]
- CAMF protocol [MeSH Supplementary Concept]
- CAMFTP protocol [MeSH Supplementary Concept]
- CAMP protocol [MeSH Supplementary Concept]
- CAMP-L protocol [MeSH Supplementary Concept]
- CAOP protocol [MeSH Supplementary Concept]
- CAP protocol 2 [MeSH Supplementary Concept]
- CAP-1 protocol [MeSH Supplementary Concept]
- CAP-M protocol [MeSH Supplementary Concept]
- CAPABLE protocol [MeSH Supplementary Concept]
- CAPE protocol [MeSH Supplementary Concept]
- CAPE-PALE protocol [MeSH Supplementary Concept]
- CAPF protocol [MeSH Supplementary Concept]
- CAPT protocol [MeSH Supplementary Concept]
- CARA protocol [MeSH Supplementary Concept]
- CAT combination [MeSH Supplementary Concept]
- CAT-G protocol [MeSH Supplementary Concept]
- CAV protocol [MeSH Supplementary Concept]
- CAV-HEM protocol [MeSH Supplementary Concept]
- CAV-T protocol [MeSH Supplementary Concept]
- CAVB protocol [MeSH Supplementary Concept]
- CBV protocol [MeSH Supplementary Concept]
- CBVPM protocol [MeSH Supplementary Concept]
- CCA protocol [MeSH Supplementary Concept]
- CCAVP16 protocol [MeSH Supplementary Concept]
- CCC protocol [MeSH Supplementary Concept]
- CCE protocol [MeSH Supplementary Concept]
- CCOM protocol [MeSH Supplementary Concept]
- CCP protocol [MeSH Supplementary Concept]
- CCV protocol [MeSH Supplementary Concept]
- CCV-AV protocol [MeSH Supplementary Concept]
- CCVPP protocol [MeSH Supplementary Concept]
- CDOP protocol [MeSH Supplementary Concept]
- CDPTH regimen [MeSH Supplementary Concept]
- CE protocol II [MeSH Supplementary Concept]
- CE-CAP protocol [MeSH Supplementary Concept]
- CEC protocol [MeSH Supplementary Concept]
- CECA protocol [MeSH Supplementary Concept]
- CEE protocol [MeSH Supplementary Concept]
- CEF regimen [MeSH Supplementary Concept]
- CEFT protocol [MeSH Supplementary Concept]
- CEMP protocol [MeSH Supplementary Concept]
- CEO-PE protocol [MeSH Supplementary Concept]
- CEOP protocol 1 [MeSH Supplementary Concept]
- CEOP protocol 2 [MeSH Supplementary Concept]
- CEOP-B protocol [MeSH Supplementary Concept]
- CEOP-IMVP-Dexa regimen [MeSH Supplementary Concept]
- CEOP-MB protocol [MeSH Supplementary Concept]
- CEP combination [MeSH Supplementary Concept]
- CEP regimen [MeSH Supplementary Concept]
- CEPP protocol [MeSH Supplementary Concept]
- CEV protocol [MeSH Supplementary Concept]
- CEVAD protocol [MeSH Supplementary Concept]
- CEVBP protocol [MeSH Supplementary Concept]
- CEVP protocol [MeSH Supplementary Concept]
- CF protocol [MeSH Supplementary Concept]
- CFMPV protocol [MeSH Supplementary Concept]
- CFP protocol [MeSH Supplementary Concept]
- CHAC-1 protocol [MeSH Supplementary Concept]
- CHAMOCA regimen [MeSH Supplementary Concept]
- CHAMOMA protocol [MeSH Supplementary Concept]
- CHAMP-5 protocol [MeSH Supplementary Concept]
- CHASE protocol [MeSH Supplementary Concept]
- CHEP protocol [MeSH Supplementary Concept]
- CHF protocol [MeSH Supplementary Concept]
- CHOEP protocol [MeSH Supplementary Concept]
- CHOP protocol [MeSH Supplementary Concept]
- CHOP protocol, modified [MeSH Supplementary Concept]
- CHOP-B protocol [MeSH Supplementary Concept]
- CHOP-V-MMV protocol [MeSH Supplementary Concept]
- CHOP-VP16 protocol [MeSH Supplementary Concept]
- CHVP protocol [MeSH Supplementary Concept]
- CHVP regimen [MeSH Supplementary Concept]
- CHVmP-VB protocol [MeSH Supplementary Concept]
- CIOD protocol [MeSH Supplementary Concept]
- CIOP protocol [MeSH Supplementary Concept]
- CIOP-Bleo protocol [MeSH Supplementary Concept]
- CISCA protocol [MeSH Supplementary Concept]
- CISCA(II)-VB(IV) protocol [MeSH Supplementary Concept]
- CMB protocol [MeSH Supplementary Concept]
- CMC protocol 2 [MeSH Supplementary Concept]
- CMCF protocol [MeSH Supplementary Concept]
- CMCp protocol [MeSH Supplementary Concept]
- CMED protocol [MeSH Supplementary Concept]
- CMF regimen [MeSH Supplementary Concept]
- CMF-B protocol [MeSH Supplementary Concept]
- CMFDV protocol [MeSH Supplementary Concept]
- CMFP protocol [MeSH Supplementary Concept]
- CMFPT protocol [MeSH Supplementary Concept]
- CMFPTH regimen [MeSH Supplementary Concept]
- CMFVP protocol [MeSH Supplementary Concept]
- CMOPP protocol [MeSH Supplementary Concept]
- CMU protocol [MeSH Supplementary Concept]
- CMVP regimen [MeSH Supplementary Concept]
- CMxMF regimen [MeSH Supplementary Concept]
- CN3OP regimen [MeSH Supplementary Concept]
- CNV protocol [MeSH Supplementary Concept]
- COAP protocol [MeSH Supplementary Concept]
- COATA protocol [MeSH Supplementary Concept]
- COBDP regimen [MeSH Supplementary Concept]
- COCE protocol [MeSH Supplementary Concept]
- CODBLAM IV protocol [MeSH Supplementary Concept]
- COF protocol [MeSH Supplementary Concept]
- COFB protocol [MeSH Supplementary Concept]
- COFP protocol 1 [MeSH Supplementary Concept]
- COFP protocol 2 [MeSH Supplementary Concept]
- COMB protocol [MeSH Supplementary Concept]
- COMET-A protocol [MeSH Supplementary Concept]
- COMF protocol [MeSH Supplementary Concept]
- COMLA protocol [MeSH Supplementary Concept]
- COMP protocol [MeSH Supplementary Concept]
- COMP-1 protocol [MeSH Supplementary Concept]
- COMP-VAN protocol [MeSH Supplementary Concept]
- COMPA protocol [MeSH Supplementary Concept]
- COMVP protocol [MeSH Supplementary Concept]
- COP protocol 1 [MeSH Supplementary Concept]
- COP protocol 2 [MeSH Supplementary Concept]
- COP-B protocol [MeSH Supplementary Concept]
- COP-BLAM protocol [MeSH Supplementary Concept]
- COP-PAF protocol [MeSH Supplementary Concept]
- COPAC protocol [MeSH Supplementary Concept]
- COPAD protocol [MeSH Supplementary Concept]
- COPADEM protocol [MeSH Supplementary Concept]
- COPE regimen [MeSH Supplementary Concept]
- COPEP protocol [MeSH Supplementary Concept]
- COPP protocol [MeSH Supplementary Concept]
- COPP-ABVD protocol [MeSH Supplementary Concept]
- COPU protocol [MeSH Supplementary Concept]
- CP protocol [MeSH Supplementary Concept]
- CPDD protocol [MeSH Supplementary Concept]
- CTCb regimen [MeSH Supplementary Concept]
- CTEC protocol [MeSH Supplementary Concept]
- CTVP protocol [MeSH Supplementary Concept]
- CV protocol [MeSH Supplementary Concept]
- CVACE protocol [MeSH Supplementary Concept]
- CVAD protocol [MeSH Supplementary Concept]
- CVAD-V protocol [MeSH Supplementary Concept]
- CVAP-B protocol [MeSH Supplementary Concept]
- CVD protocol [MeSH Supplementary Concept]
- CVP protocol 2 [MeSH Supplementary Concept]
- CVPP I protocol [MeSH Supplementary Concept]
- CVPP regimen [MeSH Supplementary Concept]
- CVPPABO protocol [MeSH Supplementary Concept]
- CWAP regimen [MeSH Supplementary Concept]
- CYOMAD protocol [MeSH Supplementary Concept]
- CYVADIC protocol [MeSH Supplementary Concept]
- CYVEDIC protocol [MeSH Supplementary Concept]
- Cis-VACD protocol [MeSH Supplementary Concept]
- CyADIC regimen [MeSH Supplementary Concept]
- D-CECaT regimen [MeSH Supplementary Concept]
- DAC protocol [MeSH Supplementary Concept]
- DAC protocol 2 [MeSH Supplementary Concept]
- DAEP protocol [MeSH Supplementary Concept]
- DAT-COAP regimen [MeSH Supplementary Concept]
- DCCM protocol [MeSH Supplementary Concept]
- DCEP protocol [MeSH Supplementary Concept]
- DD1 protocol [MeSH Supplementary Concept]
- DECAV protocol [MeSH Supplementary Concept]
- DT-PACE protocol [MeSH Supplementary Concept]
- DVP-M-CHOP protocol [MeSH Supplementary Concept]
- EACB protocol [MeSH Supplementary Concept]
- EC regimen [MeSH Supplementary Concept]
- ECAPP protocol [MeSH Supplementary Concept]
- ECBC protocol [MeSH Supplementary Concept]
- ECHO protocol [MeSH Supplementary Concept]
- ECP regimen [MeSH Supplementary Concept]
- EMA-CO protocol [MeSH Supplementary Concept]
- EPOCH protocol [MeSH Supplementary Concept]
- EVAC protocol [MeSH Supplementary Concept]
- EVDAC regimen [MeSH Supplementary Concept]
- F-MACHOP protocol [MeSH Supplementary Concept]
- FAC-MV protocol [MeSH Supplementary Concept]
- FACP protocol [MeSH Supplementary Concept]
- FCC protocol [MeSH Supplementary Concept]
- FEC protocol [MeSH Supplementary Concept]
- FEMP protocol [MeSH Supplementary Concept]
- FMC protocol [MeSH Supplementary Concept]
- GIMEMA LAL 0288 protocol [MeSH Supplementary Concept]
- HCOMLA protocol [MeSH Supplementary Concept]
- HCVAD protocol [MeSH Supplementary Concept]
- HD-CEP regimen [MeSH Supplementary Concept]
- HD-CNV protocol [MeSH Supplementary Concept]
- HEAVD protocol [MeSH Supplementary Concept]
- HM 89 protocol [MeSH Supplementary Concept]
- HM 91 protocol [MeSH Supplementary Concept]
- HiC-COM protocol [MeSH Supplementary Concept]
- ICBV regimen [MeSH Supplementary Concept]
- IVAD protocol [MeSH Supplementary Concept]
- JAC protocol [MeSH Supplementary Concept]
- L-6 protocol [MeSH Supplementary Concept]
- LALA 87 protocol [MeSH Supplementary Concept]
- LMB89 protocol [MeSH Supplementary Concept]
- LNH 84 protocol [MeSH Supplementary Concept]
- LNH 87 protocol [MeSH Supplementary Concept]
- LNH-80 regimen [MeSH Supplementary Concept]
- LNH87-2 protocol [MeSH Supplementary Concept]
- LSA(2)L(2) protocol [MeSH Supplementary Concept]
- LSA2-L2 protocol [MeSH Supplementary Concept]
- LSG15 regimen [MeSH Supplementary Concept]
- M-2 protocol [MeSH Supplementary Concept]
- M-BACOD protocol [MeSH Supplementary Concept]
- M-BACOP protocol [MeSH Supplementary Concept]
- M-BACOS protocol [MeSH Supplementary Concept]
- M-BNCOD protocol [MeSH Supplementary Concept]
- MAC III protocol [MeSH Supplementary Concept]
- MAC combination [MeSH Supplementary Concept]
- MAC conditioning regimen [MeSH Supplementary Concept]
- MACC combination [MeSH Supplementary Concept]
- MACHO protocol [MeSH Supplementary Concept]
- MACOP-B protocol [MeSH Supplementary Concept]
- MACOP-B regimen [MeSH Supplementary Concept]
- MADDOC protocol [MeSH Supplementary Concept]
- MAPECO protocol [MeSH Supplementary Concept]
- MATCOP regimen [MeSH Supplementary Concept]
- MCC protocol [MeSH Supplementary Concept]
- MCHC protocol [MeSH Supplementary Concept]
- MCHOD protocol [MeSH Supplementary Concept]
- MCOP protocol [MeSH Supplementary Concept]
- MCP 842 regimen [MeSH Supplementary Concept]
- MCPD protocol [MeSH Supplementary Concept]
- MCPP protocol [MeSH Supplementary Concept]
- MDACC protocol [MeSH Supplementary Concept]
- MECHOP-BM protocol [MeSH Supplementary Concept]
- MECY protocol [MeSH Supplementary Concept]
- MEV protocol [MeSH Supplementary Concept]
- MEV-AD protocol [MeSH Supplementary Concept]
- MEVAP protocol [MeSH Supplementary Concept]
- MI-MIV maintenance protocol [MeSH Supplementary Concept]
- ML-Y1 protocol [MeSH Supplementary Concept]
- MLL-93 protocol [MeSH Supplementary Concept]
- MMC protocol [MeSH Supplementary Concept]
- MNCOP-B protocol [MeSH Supplementary Concept]
- MOCCA protocol [MeSH Supplementary Concept]
- MOPLACE protocol [MeSH Supplementary Concept]
- MOPLEC protocol [MeSH Supplementary Concept]
- MPCCV protocol [MeSH Supplementary Concept]
- MSK-NY-II protocol, modified [MeSH Supplementary Concept]
- MTX-CHOP protocol [MeSH Supplementary Concept]
- MVP-CAB protocol [MeSH Supplementary Concept]
- MiCaT protocol [MeSH Supplementary Concept]
- MiNa protocol [MeSH Supplementary Concept]
- Murphy-Bowmann protocol [MeSH Supplementary Concept]
- N(3)-methyl-4-(diethyldithiocarbamoyl)cyclophosphamide [MeSH Supplementary Concept]
- N(3)-methyl-4-(propylthio)cyclophosphamide [MeSH Supplementary Concept]
- N,N-diethylcyclophosphamide [MeSH Supplementary Concept]
- N4SE protocol [MeSH Supplementary Concept]
- NCI PB 93-C-207 protocol [MeSH Supplementary Concept]
- NCVB protocol [MeSH Supplementary Concept]
- NEO-MACOP-B protocol [MeSH Supplementary Concept]
- OC-HDP protocol [MeSH Supplementary Concept]
- OPEC OJEC protocol [MeSH Supplementary Concept]
- OPEC protocol 1 [MeSH Supplementary Concept]
- OPEC-D protocol [MeSH Supplementary Concept]
- OXAC protocol [MeSH Supplementary Concept]
- P-COMM-B protocol [MeSH Supplementary Concept]
- P-DOCE protocol [MeSH Supplementary Concept]
- P-VEBEC protocol [MeSH Supplementary Concept]
- PAB-CAP protocol [MeSH Supplementary Concept]
- PACE-BOM protocol [MeSH Supplementary Concept]
- PACEBO protocol [MeSH Supplementary Concept]
- PATCO protocol [MeSH Supplementary Concept]
- PCAV protocol [MeSH Supplementary Concept]
- PCMF protocol [MeSH Supplementary Concept]
- PCV regimen [MeSH Supplementary Concept]
- PECC protocol [MeSH Supplementary Concept]
- PETHEMA ALL-3-97 protocol [MeSH Supplementary Concept]
- PETHEMA ALL-96 protocol [MeSH Supplementary Concept]
- PM-FAC protocol [MeSH Supplementary Concept]
- PMitCEBO protocol [MeSH Supplementary Concept]
- POCC protocol [MeSH Supplementary Concept]
- POG 8493 protocol [MeSH Supplementary Concept]
- POMACE protocol [MeSH Supplementary Concept]
- POMB-ACE protocol [MeSH Supplementary Concept]
- POMB-ACE regimen [MeSH Supplementary Concept]
- POMB-ACE-PAV regimen [MeSH Supplementary Concept]
- PROMACE protocol [MeSH Supplementary Concept]
- PROMACE-CytaBOM protocol [MeSH Supplementary Concept]
- Pro-MACE-C-MOPP protocol [MeSH Supplementary Concept]
- ProMACE-MOPP protocol [MeSH Supplementary Concept]
- ProMECE-CytaBOM protocol [MeSH Supplementary Concept]
- R-14 regimen [MeSH Supplementary Concept]
- R-CHOP protocol [MeSH Supplementary Concept]
- R-CVP protocol [MeSH Supplementary Concept]
- R-FCM protocol [MeSH Supplementary Concept]
- RACOP protocol [MeSH Supplementary Concept]
- STAMP V regimen [MeSH Supplementary Concept]
- STAMP-I protocol [MeSH Supplementary Concept]
- Stanford-NCOG protocol [MeSH Supplementary Concept]
- T-6 protocol [MeSH Supplementary Concept]
- T10 A protocol [MeSH Supplementary Concept]
- T7 protocol [MeSH Supplementary Concept]
- TAC protocol [MeSH Supplementary Concept]
- TACC protocol [MeSH Supplementary Concept]
- TCAP protocol [MeSH Supplementary Concept]
- TCCSG B-8801 protocol [MeSH Supplementary Concept]
- TCID protocol [MeSH Supplementary Concept]
- TEC protocol [MeSH Supplementary Concept]
- THP-COPBLM regimen [MeSH Supplementary Concept]
- TL-118 [MeSH Supplementary Concept]
- TMC regimen [MeSH Supplementary Concept]
- TNCF regimen [MeSH Supplementary Concept]
- TRAMPCO protocol [MeSH Supplementary Concept]
- TRAMPCOL protocol [MeSH Supplementary Concept]
- TSOP protocol [MeSH Supplementary Concept]
- UCH I protocol [MeSH Supplementary Concept]
- V-CAM protocol [MeSH Supplementary Concept]
- VAB-6 regimen [MeSH Supplementary Concept]
- VAB-III protocol [MeSH Supplementary Concept]
- VAB-IV protocol [MeSH Supplementary Concept]
- VAC protocol [MeSH Supplementary Concept]
- VAC-M protocol [MeSH Supplementary Concept]
- VAC-MAP protocol [MeSH Supplementary Concept]
- VACA protocol [MeSH Supplementary Concept]
- VACAD protocol [MeSH Supplementary Concept]
- VACIME protocol [MeSH Supplementary Concept]
- VACO-B protocol [MeSH Supplementary Concept]
- VACOP-B protocol [MeSH Supplementary Concept]
- VAP-cyclo protocol [MeSH Supplementary Concept]
- VAPAC protocol [MeSH Supplementary Concept]
- VAPEC-B protocol [MeSH Supplementary Concept]
- VBCMF protocol [MeSH Supplementary Concept]
- VCAA protocol [MeSH Supplementary Concept]
- VCAD regimen [MeSH Supplementary Concept]
- VCAV protocol [MeSH Supplementary Concept]
- VCCP protocol [MeSH Supplementary Concept]
- VCD protocol [MeSH Supplementary Concept]
- VCDP protocol [MeSH Supplementary Concept]
- VCMA protocol [MeSH Supplementary Concept]
- VCP protocol 2 [MeSH Supplementary Concept]
- VCPC protocol [MeSH Supplementary Concept]
- VCRP protocol [MeSH Supplementary Concept]
- VCSP protocol [MeSH Supplementary Concept]
- VDBCP protocol [MeSH Supplementary Concept]
- VEBEP regimen [MeSH Supplementary Concept]
- VECABOP protocol [MeSH Supplementary Concept]
- VEMFAH protocol [MeSH Supplementary Concept]
- VEMP protocol 1 [MeSH Supplementary Concept]
- VEMP protocol 3 [MeSH Supplementary Concept]
- VEP-THP protocol [MeSH Supplementary Concept]
- VEPA-B protocol [MeSH Supplementary Concept]
- VEPA-L protocol [MeSH Supplementary Concept]
- VEPA-M protocol [MeSH Supplementary Concept]
- VEPEMB protocol [MeSH Supplementary Concept]
- VETOPEC protocol [MeSH Supplementary Concept]
- VHCP protocol [MeSH Supplementary Concept]
- VICED protocol [MeSH Supplementary Concept]
- VICOP-B protocol [MeSH Supplementary Concept]
- VMCP protocol [MeSH Supplementary Concept]
- VNCOP-B protocol [MeSH Supplementary Concept]
- VPC protocol [MeSH Supplementary Concept]
- VPCBAE protocol [MeSH Supplementary Concept]
- VQEP protocol [MeSH Supplementary Concept]
- VbCFM protocol [MeSH Supplementary Concept]
- VinMCP protocol [MeSH Supplementary Concept]
- alcophosphamide [MeSH Supplementary Concept]
- asta Z 7557 [MeSH Supplementary Concept]
- cyclone protocol [MeSH Supplementary Concept]
- d4-cyclophosphamide [MeSH Supplementary Concept]
- dechloroethylcyclophosphamide [MeSH Supplementary Concept]
- diiodocyclophosphamide [MeSH Supplementary Concept]
- hexa CAF protocol [MeSH Supplementary Concept]
- hyperCDT protocol [MeSH Supplementary Concept]
- iminophosphamide [MeSH Supplementary Concept]
- iodocyclophosphamide [MeSH Supplementary Concept]
- m-ACOD protocol [MeSH Supplementary Concept]
- m-BECOD protocol [MeSH Supplementary Concept]
- m-M-BACOD protocol [MeSH Supplementary Concept]
- mafosfamide [MeSH Supplementary Concept]
- mafosfamide-lysine [MeSH Supplementary Concept]
- mallinson protocol [MeSH Supplementary Concept]
- malmo protocol [MeSH Supplementary Concept]
- maphosphamide [MeSH Supplementary Concept]
- new york protocol [MeSH Supplementary Concept]
- perfosfamide [MeSH Supplementary Concept]
- phenylketophosphamide [MeSH Supplementary Concept]
- protocol 8001 [MeSH Supplementary Concept]
- rosen's T-10 protocol [MeSH Supplementary Concept]
- st jude's regimen [MeSH Supplementary Concept]
- stanford university protocol [MeSH Supplementary Concept]
- sufosfamide [MeSH Supplementary Concept]
- trofosfamide [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Cyclophosphamide [ICD-11 Extension code]
- Cyclophosphamide [NCIt concept]
- Cyclophosphamide [LOINC component]
- Cyclophosphamide (substance) [SNOMED CT concept]
- Product containing cyclophosphamide (medicinal product) [SNOMED CT concept]
- cyclophosphamide [ATC Code]
- cyclophosphamide [Substance BNPC]
- cyclophosphamide [SNOMED Notion]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients